|
CAS No. | 137862-53-4 |
Chemical Name: | 3-Methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]-butanoic acid |
Synonyms: | Nisis;Tareg;DIOVAN;CGP-48933;VALSARTAN;Valsratan;Valsartane;L-Valsartan;Valsartan99%;Valsartan API |
CBNumber: | CB6182539 |
Molecular Formula: | C24H29N5O3 |
Formula Weight: | 435.52 |
MOL File: | 137862-53-4.mol |
|
|
|
|
3-Methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]-butanoic acid Property |
|
storage temp. : |
-20°C Freezer, Under inert atmosphere |
|
|
|
|
3-Methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]-butanoic acid Chemical Properties,Usage,Production |
Chemical Properties
White Crystalline Powder |
|
Usage
A nonpeptide angiotensin II AT1-receptor antagonist. Antihypertensive. |
|
Usage
Angiotensin II inhibitor, antihypertensive |
|
Usage
May be used as a first line agent to treat uncomplicated hypertension, isolated systolic hypertension and left ventricular hypertrophy. May be used as a first line agent to delay progression of diabetic nephropathy. Losartan may be also used as a second l |
|
|
3-Methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]-butanoic acid Suppliers Global( 296)Suppliers |
|
|
|
|
N-(1-OXOPENTYL)-N-[[2'-(1H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]METHYL]-L-VALINE
VALSARTAN
CGP-48933
DIOVAN
3-methyl-2-[pentanoyl-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]amino]-butanoic acid
137862-53-4
VALSARTAN, MM STANDARD
VALSARTAN, USP STANDARD
VALSARTAN, RELATED COMPOUND A(R)-N-VALERYL-N-([2'-(1-H-TETRAZOLE)-5-YL)-BIPHENYL-4-YL]-METHYL)-VALINE USP STANDARD
VALSARTAN, RELATED COMPOUND C(S)-N-VALERYL-N-([2'-(1-H-TETRAZOLE)-5-YL)-BIPHENYL-4-YL]-METHYL)-VALINE BENZYL ESTER USP STANDARD
Valsartan99%
N-[[(2-Cyano(1.1-Biphenyl)-4-Yl)Methyl]MethylEster]-L-Valine.Hydrochloride
ValsartanC24H29N503
Valsartane
C24H29N5O3
Diovan, N-(1-Oxopentyl)-N-[[2(1H-tetrazol-5-yl)[1,1biphenyl]-4-yl]methyl]-L-valine, CGP-48933
N-(1-N.PENTANOYL)-N-[[2''-(1H-TETRAZOL-5-YL)[1'',1- BIPHENYL]-4-YL]METHYL]-L-VALINE/VALSARTAN
L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI)
Nisis
Tareg
Active Pharmaceutical Ingredients
Antihypertensive
Valsratan
(S)-2-(N-((2''-(1H-TETRAZOL-5-YL)BIPHENYL-4-YL)METHYL)PENTANAMIDO)-3-METHYLBUTANOIC ACID
Valsartan Related Compound A (10 mg) ((R)-N-Valeryl-N-([2'-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl)-valine)
APIs
N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-
Intermediates & Fine Chemicals
Pharmaceuticals
API's
N-(1-Oxopentyl)-N-[[2’-(1H-tetrazol-5-y1)[1,1'-biphenyl]-4-y1]methyl]-L-valine
L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-
C24H28N5O3
N-(1-Oxopentyl)-N-[[2'-(2H-tetrazo-5-yl)
Valsartan (350 mg)G0F0650.997mg/mg(an)
Valsartan (350 mg)
3-Methyl-2-[pentanoy
Aromatics
Chiral Reagents
Heterocycles
(S)-2-(N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)pentanaMido)-3-Methylbutanoic acid
Valsartan API
Valsartan (>99% pure)
N-Valeryl-N-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-L-valine
(2S)-3-Methyl-2-[N-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}Methyl)pentanaMido]butanoic acid
L-Valsartan
2-(N-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)pentanaMido)-3-Methylbutanoic acid
API Reference Standard
Free Base API
DIOVAN
((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-L-valine
N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine
|